LATEST NEWS
December 18, 2015 | Company Announcements
Bavarian Nordic Enters Licensing and Collaboration Agreement with Janssen for MVA-BN® in the Development of a Therapeutic HPV VaccineDecember 08, 2015 | Company Announcements
Bavarian Nordic Introduces Incentive Program for all Employees and Issues Warrants to Executive Management and Certain EmployeesNovember 30, 2015 | Company Announcements
Total number of voting rights and share capital in Bavarian Nordic A/SNovember 16, 2015 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant ExerciseNovember 03, 2015 | Company Announcements
Bavarian Nordic Announces Results of a Phase 1 Trial Investigating Brachyury Specific Cancer Vaccine in Patients with Advanced CancersNovember 03, 2015 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Nine Months of 2015 October 28, 2015 | Company Announcements
Bavarian Nordic Announces Expansion of IMVAMUNE® Orders from Canadian Government